PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26983878-8	2016	BETi preferentially target super-enhancer-regulated genes, and a super-enhancer in c-MYC was recently identified in HCT116 cells to which BRD4 and effector transcription factors of the WNT/beta-catenin/TCF and MEK/ERK pathways are recruited.	beti	0-4	bromodomain containing 4	Homo sapiens	138-142	
26983878-8	2016	BETi preferentially target super-enhancer-regulated genes, and a super-enhancer in c-MYC was recently identified in HCT116 cells to which BRD4 and effector transcription factors of the WNT/beta-catenin/TCF and MEK/ERK pathways are recruited.	beti	0-4	catenin beta 1	Homo sapiens	189-201	
26983878-8	2016	BETi preferentially target super-enhancer-regulated genes, and a super-enhancer in c-MYC was recently identified in HCT116 cells to which BRD4 and effector transcription factors of the WNT/beta-catenin/TCF and MEK/ERK pathways are recruited.	beti	0-4	hepatocyte nuclear factor 4 alpha	Homo sapiens	202-205	
26983878-8	2016	BETi preferentially target super-enhancer-regulated genes, and a super-enhancer in c-MYC was recently identified in HCT116 cells to which BRD4 and effector transcription factors of the WNT/beta-catenin/TCF and MEK/ERK pathways are recruited.	beti	0-4	mitogen-activated protein kinase kinase 7	Homo sapiens	210-213	
26983878-8	2016	BETi preferentially target super-enhancer-regulated genes, and a super-enhancer in c-MYC was recently identified in HCT116 cells to which BRD4 and effector transcription factors of the WNT/beta-catenin/TCF and MEK/ERK pathways are recruited.	beti	0-4	mitogen-activated protein kinase 1	Homo sapiens	214-217	
26983878-10	2016	These findings demonstrate that BETi downregulate c-MYC expression and inhibit colorectal cancer cell proliferation and identify strategies for enhancing the effects of BETi on c-MYC repression by combinatorial targeting the c-MYC super-enhancer.	beti	32-36	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	50-55	
26983878-10	2016	These findings demonstrate that BETi downregulate c-MYC expression and inhibit colorectal cancer cell proliferation and identify strategies for enhancing the effects of BETi on c-MYC repression by combinatorial targeting the c-MYC super-enhancer.	beti	169-173	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	177-182	
26983878-10	2016	These findings demonstrate that BETi downregulate c-MYC expression and inhibit colorectal cancer cell proliferation and identify strategies for enhancing the effects of BETi on c-MYC repression by combinatorial targeting the c-MYC super-enhancer.	beti	169-173	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	177-182